A Phase 2 Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)

Clinical trial NCT01896583 · COMPLETED

Trial details

NCT number: NCT01896583
Sponsor: Seldar Pharma, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diarrhea Predominant Irritable Bowel Syndrome

Start date: 2013-11-01
Primary completion: 2014-03-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.